NYSE:NTRNutrien Stock Price, Forecast & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NTR stock has decreased by 0.7% and is now trading at $31.78. View which stocks have been most impacted by Coronavirus.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 1 sell rating, 6 hold ratings, 13 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Nutrien.

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Nutrien.

Nutrien Ltd (NYSE:NTR) posted its earnings results on Wednesday, May, 6th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.08. The business earned $4.19 billion during the quarter, compared to analysts' expectations of $3.44 billion. Nutrien had a net margin of 4.49% and a return on equity of 4.66%. Nutrien's revenue was up 12.6% compared to the same quarter last year. During the same period last year, the company posted $0.20 EPS. View Nutrien's earnings history.

Nutrien declared a quarterly dividend on Wednesday, May 6th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.45 per share on Friday, July 17th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 5.66%. The ex-dividend date of this dividend is Monday, June 29th. View Nutrien's dividend history.

Nutrien updated its FY20 earnings guidance on Wednesday, May, 6th. The company provided earnings per share guidance of $1.50-2.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.00.

21 equities research analysts have issued 12-month price objectives for Nutrien's stock. Their forecasts range from $36.00 to $70.00. On average, they anticipate Nutrien's stock price to reach $49.30 in the next twelve months. This suggests a possible upside of 55.1% from the stock's current price. View analysts' price targets for Nutrien.

News headlines about NTR stock have trended negative on Wednesday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Nutrien earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about Nutrien.

Nutrien saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 2,550,000 shares, a drop of 10.8% from the June 15th total of 2,860,000 shares. Based on an average trading volume of 1,640,000 shares, the days-to-cover ratio is currently 1.6 days. Approximately 0.5% of the shares of the company are sold short. View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include Scotts Miracle-Gro (SMG), CF Industries (CF), Mosaic (MOS), Nufarm (NUF), American Vanguard (AVD), Marrone Bio Innovations (MBII), Calyxt (CLXT), CVR Partners (UAN), Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Eden Research (EDEN), Evogene (EVGN), Bion Environmental Technologies (BNET), China Green Agriculture (CGA) and SenesTech (SNES). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include General Electric (GE), Bank of America (BAC), Cimarex Energy (XEC), Johnson & Johnson (JNJ), Intel (INTC), AT&T (T), Exxon Mobil (XOM), Micron Technology (MU), Verizon Communications (VZ) and Pfizer (PFE).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a variety of retail and institutional investors. Top institutional investors include Envestnet Asset Management Inc. (0.03%), PM CAPITAL Ltd (0.03%) and Cardinal Capital Management Inc. (0.00%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc..

NTR stock was acquired by a variety of institutional investors in the last quarter, including PM CAPITAL Ltd, and Cardinal Capital Management Inc..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $31.78.

Nutrien has a market capitalization of $18.11 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]